DAL vs DNTH · P/E 12, rev $61.64B vs rev $6.2M
Delta Air Lines Inc (DAL) versus Dianthus Therapeutics Inc. (DNTH) — a side-by-side from cached financials, not a winner call.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Latest reported DAL revenue for 2024-12-31 was $61.64B. Net income was $3.46B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
DAL currently screens at market cap $52.18B and trailing P/E 11.6. DNTH currently screens at market cap $4.40B.
Not investment advice. Open the DAL and DNTH stock pages for the full models.
Not investment advice.